These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine. Foley R; Tozer R; Wan Y Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436 [TBL] [Abstract][Full Text] [Related]
3. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells. Diebold SS; Cotten M; Koch N; Zenke M Gene Ther; 2001 Mar; 8(6):487-93. PubMed ID: 11313828 [TBL] [Abstract][Full Text] [Related]
4. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells. Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812 [TBL] [Abstract][Full Text] [Related]
5. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. Breckpot K; Dullaers M; Bonehill A; van Meirvenne S; Heirman C; de Greef C; van der Bruggen P; Thielemans K J Gene Med; 2003 Aug; 5(8):654-67. PubMed ID: 12898635 [TBL] [Abstract][Full Text] [Related]
6. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy. Dullaers M; Thielemans K J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497 [TBL] [Abstract][Full Text] [Related]
7. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages. Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848 [TBL] [Abstract][Full Text] [Related]
8. Genetically modified dendritic cells for cancer immunotherapy. Ribas A Curr Gene Ther; 2005 Dec; 5(6):619-28. PubMed ID: 16457651 [TBL] [Abstract][Full Text] [Related]
9. Feeding dendritic cells with tumor antigens: self-service buffet or à la carte? Melero I; Vile RG; Colombo MP Gene Ther; 2000 Jul; 7(14):1167-70. PubMed ID: 10918484 [TBL] [Abstract][Full Text] [Related]
10. Gene-modified dendritic cells for immunotherapy against cancer. Lundqvist A; Pisa P Med Oncol; 2002; 19(4):197-211. PubMed ID: 12512913 [TBL] [Abstract][Full Text] [Related]
11. [Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors]. Okada N Yakugaku Zasshi; 2001 Aug; 121(8):593-600. PubMed ID: 11523120 [TBL] [Abstract][Full Text] [Related]
12. Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5. Le Gallo M; Toutirais O; Montier T; Cabillic F; Bouet F; Delépine P; Lehn P; Jotereau F; Catros V J Gene Med; 2008 Jun; 10(6):628-36. PubMed ID: 18338820 [TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy. Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612 [TBL] [Abstract][Full Text] [Related]